These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22434428)

  • 1. Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study.
    Nabhan C; Byrtek M; Taylor MD; Friedberg JW; Cerhan JR; Hainsworth JD; Miller TP; Hirata J; Link BK; Flowers CR
    Cancer; 2012 Oct; 118(19):4842-50. PubMed ID: 22434428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.
    Nastoupil LJ; Sinha R; Byrtek M; Zhou X; Taylor MD; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR
    Cancer; 2014 Jun; 120(12):1830-7. PubMed ID: 24668580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.
    Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK
    Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular lymphoma in the United States: first report of the national LymphoCare study.
    Friedberg JW; Taylor MD; Cerhan JR; Flowers CR; Dillon H; Farber CM; Rogers ES; Hainsworth JD; Wong EK; Vose JM; Zelenetz AD; Link BK
    J Clin Oncol; 2009 Mar; 27(8):1202-8. PubMed ID: 19204203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
    Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
    Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
    Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Zhou X; Taylor M; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR
    Br J Haematol; 2016 Mar; 172(5):724-34. PubMed ID: 26729445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance rituximab in Veterans with follicular lymphoma.
    Halwani AS; Rasmussen KM; Patil V; Morreall D; Li C; Yong C; Burningham Z; Dawson K; Masaquel A; Henderson K; DeLong-Sieg E; Sauer BC
    Cancer Med; 2020 Oct; 9(20):7537-7547. PubMed ID: 32860335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
    Casulo C; Byrtek M; Dawson KL; Zhou X; Farber CM; Flowers CR; Hainsworth JD; Maurer MJ; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
    J Clin Oncol; 2015 Aug; 33(23):2516-22. PubMed ID: 26124482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.
    Nabhan C; Byrtek M; Rai A; Dawson K; Zhou X; Link BK; Friedberg JW; Zelenetz AD; Maurer MJ; Cerhan JR; Flowers CR
    Br J Haematol; 2015 Jul; 170(1):85-95. PubMed ID: 25851937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).
    Wagner-Johnston ND; Link BK; Byrtek M; Dawson KL; Hainsworth J; Flowers CR; Friedberg JW; Bartlett NL
    Blood; 2015 Aug; 126(7):851-7. PubMed ID: 26105149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in survival in malignant germ cell tumors of the ovary.
    Hinchcliff E; Rauh-Hain JA; Clemmer JT; Diver E; Hall T; Stall J; Growdon W; Clark R; Schorge J
    Gynecol Oncol; 2016 Mar; 140(3):463-9. PubMed ID: 26773470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
    Binkley MS; Brady JL; Hajj C; Chelius M; Chau K; Balogh A; Levis M; Filippi AR; Jones M; Ahmed S; MacManus M; Wirth A; Oguchi M; Vistisen AK; Andraos TY; Ng AK; Aleman BMP; Choi SH; Kirova YM; Hardy S; Reinartz G; Eich HT; Bratman SV; Constine LS; Suh CO; Dabaja B; El-Galaly TC; Hodgson DC; Ricardi U; Yahalom J; Mikhaeel NG; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):522-529. PubMed ID: 30858143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study.
    Rajguru S; Kristinsdottir T; Eickhoff J; Peterson C; Meyer CM; Traynor AM; Kahl BS
    Clin Adv Hematol Oncol; 2014 Aug; 12(8):509-15. PubMed ID: 25356575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy.
    Yuan J; Greiner TC; Fu K; Smith LM; Aoun P; Chan WC; Bierman PJ; Bociek RG; Vose JM; Armitage JO; Weisenburger DD
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):488-497.e2. PubMed ID: 28842137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
    Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group.
    Paszkiewicz-Kozik E; Debowska M; Jakacka N; Kotarska M; Szymanski M; Wisniewski K; Konska A; Jarzembowska M; Drozd-Sokolowska J; Romejko-Jarosinska J; Szumera-Cieckiewicz A; Rymkiewicz G; Ziarkiewicz-Wroblewska B; Lech-Maranda E; Walewski J; Hus I
    Chemotherapy; 2022; 67(4):201-210. PubMed ID: 35249035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma.
    Tari A; Kitadai Y; Mouri R; Takigawa H; Asaoku H; Mihara K; Takata K; Fujihara M; Yoshino T; Koga T; Fujimori S; Tanaka S; Chayama K
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1461-1468. PubMed ID: 29377265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials.
    Chavez-MacGregor M; Unger JM; Moseley A; Ramsey SD; Hershman DL
    Cancer; 2018 Apr; 124(8):1760-1769. PubMed ID: 29370458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.